Kara Anfal, Massaro Chiara, Giammanco Giovanni M, Alduina Rosa, Boussoualim Naouel
Laboratory of Applied Biochemistry, Faculty of Nature and Life Sciences, University Ferhat Abbas of Setif 1, Setif 19000, Algeria.
Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Viale delle Scienze, Bldg. 16, 90128 Palermo, Italy.
Antibiotics (Basel). 2024 Aug 15;13(8):773. doi: 10.3390/antibiotics13080773.
Urinary tract infections (UTIs) caused by represent a significant public health concern due to the high virulence and antimicrobial resistance exhibited by these pathogens. This study aimed to analyze the phylogenetic diversity and antibiotic resistance profiles of Uropathogenic (UPEC) strains isolated from UTI patients in Algeria, focusing on virulence factors such as extended β-lactamase (ESBL) production, biofilm formation, and hemolytic activity. Phylogenetic grouping of 86 clinical imipenem resistant isolates showed the prevalence of group B2 (48.9%), followed by groups E (22.1%), unknown (12.8%), A (8.1%), and B1 (4.7%), and Clade I, D, Clade I, or Clade II (1.2%). The highest resistance rates were observed towards amoxicillin (86.04%), ticarcillin (82.55%), piperacillin (73.25%), nitrofurantoin (84.88%), and trimethoprim-sulfamethoxazole (51.16%). Notably, 69.8% of UPEC strains were multidrug-resistant (MDR) and 23.2% were extensively drug-resistant (XDR). Additionally, 48.9%, 42%, and 71% of strains demonstrated ESBL production, hemolytic activity, and weak biofilm production, respectively. Continuous monitoring and characterization of UPEC strains are essential to track the spread of the most resistant and virulent phylogenetic groups over time, facilitating rapid therapeutic decisions to treat infections and prevent the emergence of new resistant organisms, helping choose the most effective antibiotics and reducing treatment failure.
由[病原体名称未给出]引起的尿路感染(UTIs)是一个重大的公共卫生问题,因为这些病原体表现出高毒力和抗菌耐药性。本研究旨在分析从阿尔及利亚尿路感染患者中分离出的尿路致病性[病原体名称未给出](UPEC)菌株的系统发育多样性和抗生素耐药谱,重点关注诸如超广谱β-内酰胺酶(ESBL)产生、生物膜形成和溶血活性等毒力因子。对86株临床耐亚胺培南[病原体名称未给出]分离株进行系统发育分组,结果显示B2组占比最高(48.9%),其次是E组(22.1%)、未知组(12.8%)、A组(8.1%)、B1组(4.7%)以及进化枝I、D、进化枝I或进化枝II(1.2%)。观察到对阿莫西林(86.04%)、替卡西林(82.55%)、哌拉西林(73.25%)、呋喃妥因(84.88%)和甲氧苄啶-磺胺甲恶唑(51.16%)的耐药率最高。值得注意的是,69.8%的UPEC菌株为多重耐药(MDR),23.2%为广泛耐药(XDR)。此外,分别有48.9%、42%和71%的菌株表现出ESBL产生、溶血活性和弱生物膜产生。持续监测和鉴定UPEC菌株对于追踪最具耐药性和毒力的系统发育群体随时间的传播至关重要,有助于做出快速治疗决策以治疗感染并防止新的耐药生物体出现,有助于选择最有效的抗生素并减少治疗失败。